BAT Cow's Milk for the Replacement of the Food Challenge Test
Basophil Activation Test (BAT) Cow's Milk as a Replacement for the Expensive, Burdensome and Risky Food Challenge Tes
1 other identifier
observational
700
1 country
1
Brief Summary
The prevalence of children suspected of a cow's milk allergy is 17% in the Netherlands. Cow's milk diagnosis is based on a food challenge test However, this food challenge test is expensive, time consuming, risky, with waiting lists of several months. This waiting time results in unnecessarily long-term use of expensive hypoallergenic milk formula Therefore, there is a great need to introduce a better and faster diagnostic test for cow's milk allergy diagnosis in standard care. The in vitro Basophil Activation Test (BAT) is cheap, quick (result \< 1 day, no waiting list), safe for the child and is a reliable alternative for the food challenge test to diagnose an IgE-mediated allergy. A diagnostic work-up with the BAT is expected to achieve a relevant reduction in the number of expensive and risky food challenges and the prescription of hypoallergenic formula. The reduction in diagnostic delay will increase quality of life. Objective: Determination of the (cost)effectiveness of the replacement of the expensive, risky and time-consuming food challenge test by the Basophil Activation Test (BAT) for the diagnosis of an IgE-mediated cow's milk allergy in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2021
CompletedFirst Posted
Study publicly available on registry
October 1, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMay 3, 2022
May 1, 2022
4.1 years
September 21, 2021
May 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of the in vitro Basophil Activation Test (BAT) Cow's Milk
3 months
Secondary Outcomes (3)
Cost-effectiveness of the BAT cow's milk
1 year
Food allergy Quality of life
Before and one month after the food challenge test
Health related Quality of life
Before and one month after the food challenge test
Study Arms (1)
Children with suspected cow's milk allergy
Interventions
The burden for child/parents in this study is low as it is limited to a single blood draw, which is already necessary for usual diagnostic care in about 70% of the children
Eligibility Criteria
Children suspected of an IgE-mediated cow's milk allergy and are eligible for a food challenge test at 2nd and 3rd line allergy centres.
You may qualify if:
- Age 0-12 years
- Suspected of cow's milk allergy with one or more of the following complaints after intake of cow's milk:
- angioedema
- urticaria
- sneezing and rhinitis \<2 hours after feeding
- sensation of swelling in the throat and/or difficulty swallowing \<2 hours after feeding
- voice change/hoarseness \<2 hours after feeding
- cough \<2 hours after feeding
- wheezing and/or shortness of breath \<2 hours after feeding
- loss of consciousness \<2 hours after feeding
- vomiting or abdominal pain or diarrhoea \<2 hours after feeding in children \<4 years only in combination with IgE-mediated complaints in other tracts
- Placed on a waiting list for a hospital food challenge test
- Blood draw for cow's milk sIgE and BAT \< 3 months before the food challenge test. This blood draw will be simultaneously scheduled with a blood draw for regular diagnostics.
- Signed informed consent parents/guardians
You may not qualify if:
- Age \> 12 years
- Suspicion of Food Protein-Induced Enterocolitis Syndrome (FPIES)
- Eosinophilic esophagitis due to a cow's milk allergy
- Suspected cow's milk allergy \<4 years with crying and/or agitation and/or eczema and/or abdominal pain and/or failure to thrive and/or blood loss per anum and/or diarrhoea and/or reflux and/or vomiting as the only manifestation of the allergy without IgE-mediated symptoms in another organ system
- Systemic immunosuppressant use
- Other underlying chronic conditions (immunological, oncological, chromosomal abnormalities).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rijnstate Hospitallead
- Alrijne Hospitalcollaborator
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)collaborator
- Bernhoven Hospitalcollaborator
- Catharina Ziekenhuis Eindhovencollaborator
- Elkerliek Hospitalcollaborator
- Erasmus Medical Centercollaborator
- Elisabeth-TweeSteden Ziekenhuiscollaborator
- Maasstadziekenhuiscollaborator
- Meander Medisch Centrumcollaborator
- OLVGcollaborator
- Spaarne Gasthuiscollaborator
- Franciscus Gasthuiscollaborator
- University Medical Center Groningencollaborator
- UMC Utrechtcollaborator
- Viecurie Medisch Centrum voor Noord LImburgcollaborator
- Zuyderland Medisch Centrumcollaborator
Study Sites (1)
Janneke Ruinemans
Arnhem, Gelderland, 6815 AD, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2021
First Posted
October 1, 2021
Study Start
November 1, 2021
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
May 3, 2022
Record last verified: 2022-05